SBSuman Bhandary

Suman Bhandary

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Suman Bhandary has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Functionalized Mesoporous Silica Nanoparticles for the Delivery of 3,3'-diindolylmethane to Triple-negative Breast Cancer Cells

    by Yashaswi Dutta Gupta, Rupali Sarkar, Arijit Bhowmik, Neelanjana Bag, Subhadip Hajra, Sukhen Das, Suman Bhandary

    Background: Despite advancements in cancer therapy, the delivery of anti-cancer agents remains a significant challenge due to the toxicity of conventional treatments to healthy tissues, and the limited solubility and bioavailability of some therapeutic agents. Delivery systems based on nanoparticles have emerged as an effective way to address these issues. Objectives: The primary goal of this study was to assess the ability of functionalized Mesoporous Silica Nanoparticles (fMSNs) to transport 3,3'-diindolylmethane (DIM), a hydrophobic anticancer drug, to efficiently target Triple-Negative Breast Cancer cells (TNBCs), while posing the least number of adverse effects on cells that are healthy, and to evaluate the mechanism of action and potential cytotoxicity of DIM-fMSNs on TNBC cells. Methods: Functionalized mesoporous silica nanoparticles were synthesized and characterized for uniformity and functionalization. DIM, a hydrophobic indole-based phytochemical, was loaded into the fMSNs to create DIM-fMSNs. The drug delivery system was tested in vitro on TNBC cells to assess its cellular uptake, bioavailability, and cytotoxic effects. Mechanistic studies were conducted to determine the pathways involved in DIM-fMSNs-induced cell death. Results: Our findings demonstrate that the fMSNs effectively delivered drugs to MDA-MB-231 cell lines, resulting in significant suppression of the growth of cancer cells, and enhanced therapeutic efficacy in vitro, whilst demonstrating effective penetration into TNBC cells even at low concentrations. In vitro tests also showed that our nano-formulation was superior to toxic chemotherapy drugs like Doxorubicin in the treatment of TNBC at lower drug concentrations. Mechanistic studies involving the identification of key apoptotic proteins revealed that DIM-fMSNs induced mitochondriamediated apoptosis as the underlying mechanism of cell death in TNBC cells. The formulation demonstrated increased therapeutic efficacy and drug bioavailability with fewer harmful side effects on nearby normal cells and tissues. Conclusion: The study highlights the potential of DIM-loaded fMSNs as a potentially effective therapeutic approach for TNBC treatment. The use of fMSNs improved the solubility, bioavailability, and delivery of DIM, resulting in enhanced efficacy and reduced toxicity, introducing an innovative approach to future cancer therapies.

  • Nano‐Revolution: Harnessing Silica Nanoparticles for Next‐Generation Cancer Therapeutics

    by Yashaswi Dutta Gupta, Suman Bhandary

    Silica nanoparticles (SiNPs) emerge as a promising material in the realm of nanotechnology, boasting a unique combination of compatibility with living tissues, adaptable characteristics, and easily customizable surfaces, making them an attractive foundation for innovative cancer therapies. SiNPs permit the efficient loading of therapeutic agents, nucleic acids, and imaging agents, leveraging their structural design for enhanced payload capacity. The ability to precisely tune their dimensions, morphology, and surface properties allows controlled regulation of drug release timing and localization, thereby improving therapeutic precision and reducing unintended impacts on healthy tissues. Surface functionalization with ligands, antibodies, or peptides facilitates active targeting of cancer cells, boosting tumor‐specific drug accumulation and reducing systemic toxicity. Beyond drug delivery, SiNPs excel in photothermal and photodynamic therapies. The light‐responsive nature of these nanoparticles facilitates efficient photon‐to‐energy conversion, generating localized hyperthermia or cytotoxic reactive species for selective tumor ablation. Additionally, their dual role as contrast enhancers in imaging techniques like MRI and fluorescence enables real‐time visualization of therapeutic response and tumor dynamics. Despite their promise, challenges like durable biological compatibility, immune system reactions, and scalable production need further development for clinical use. Ongoing studies prioritize optimizing nanostructure architecture, surface functionalization, and formulation methodologies to overcome existing challenges. In summary, SiNPs signify pioneering advancements in precision oncology, offering tailored therapeutic strategies. Their versatility enables multimodal therapies and image‐guided treatments and minimizes adverse effects. Collaborative interdisciplinary efforts and continuous innovation are essential to unlocking their full capabilities, driving the development of next‐generation precision oncology tailored to improve patient prognosis.


  • Open Access

    HPLC based Phytochemicals Analysis of Phyllanthus emblica (Indian Gooseberry/Amla): A mini Review

    by S Dutta, S Bhandary, S Haldar, S Bandyopadhyay

    High-Pressure Liquid Chromatography (HPLC) is an analytical tool extensively used for the scientific analysis of components in a mixture. Several reports attribute its high analytical potential to bioactive components from different medicinal plants. Hepatic disorders, which have been a major threat to public health for decades, affect cells, tissues, structure, or liver function. The damage caused by this can be triggered by biological causes, autoimmune diseases, excessive alcohol consumption, or the action of different compounds, for instance, few medicines. Phyllanthus emblica Linn. is a therapeutic plant that has been used to treat liver disorders in Asia for many decades now. It is mentioned in the Ayurvedic scriptures for its medicinal value. This review focuses on the intricacies of HPLC-based extraction and analysis of medicinally important phytochemicals, notably for hepatic disorders from the P. emblica plant. This will be useful for future phytochemical analysts working with medicinal plants.


  • Top Cited Papers
    Open Access

    Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics

    by Yashaswi Dutta Gupta, Yuri Mackeyev, Sunil Krishnan, Suman Bhandary

    Owing to unique facets, such as large surface area, tunable synthesis parameters, and ease of functionalization, mesoporous silica nanoparticles (MSNs) have transpired as a worthwhile platform for cancer theranostics over the last decade. The full potential of MSNs in cancer theranostics, however, is yet to be realized. While MSNs can be employed for targeted drug delivery and imaging, their effectiveness can frequently be hindered by factors, such as biological barriers, complex tumor microenvironment, target non-specificity and ineffectiveness of individual functionalized moieties. The primary purpose of this review is to highlight technological advances such as tumor-specific, stimuli-responsive “smart” MSNs and multimodal MSN-based hybrid nanoplatforms that have the potential to overcome these limitations and improve MSN effectiveness in cancer theranostics. This article offers an extensive overview of MSN technology in cancer theranostics, outlining key directions for future research as well as the challenges that are involved in this aspect. We aim to underline the vitality of MSN technology and the relevance of current research and advancements in this field to potentially enhance clinical outcomes through the provision of more precise and focused theranostic approaches.


  • A facile vacuum assisted synthesis of nanoparticle impregnated hydroxyapatite composites having excellent antimicrobial properties and biocompatibility

    by Somtirtha Banerjee, Biswajoy Bagchi, Suman Bhandary, Arpan Kool, Nur Amin Hoque, Pradip Thakur, Sukhen Das


  • Open Access

    Anti-SSTR2 peptide based targeted delivery of potent PLGA encapsulated 3,3’-diindolylmethane nanoparticles through blood brain barrier prevents glioma progression

    by Arijit Bhowmik, Sayak Chakravarti, Aparajita Ghosh, Rajni Shaw, Suman Bhandary, Satyaranjan Bhattacharyya, Parimal C Sen, Mrinal K Ghosh

    Anti-SSTR2 peptide based targeted delivery of potent PLGA encapsulated 3,3’-diindolylmethane nanoparticles through blood brain barrier prevents glioma progression Anti-SSTR2 peptide based targeted delivery of potent PLGA encapsulated 3,3′-diindolylmethane nanoparticles through blood brain barrier prevents glioma progression


  • Formulation and antitumorigenic activities of nanoencapsulated nifetepimine: A promising approach in treating triple negative breast carcinoma

    by Aparajita Ghosh, Arijit Bhowmik, Suman Bhandary, Salil Putatunda, Aparna Laskar, Atanu Biswas, Sandip Dolui, Bhaswati Banerjee, Rajni Khan, Nirmalendu Das, et al.


  • Synthesis of eucalyptus/tea tree oil absorbed biphasic calcium phosphate–PVDF polymer nanocomposite films: a surface active antimicrobial system for biomedical application

    by Biswajoy Bagchi, Somtirtha Banerjee, Arpan Kool, Pradip Thakur, Suman Bhandary, Nur Amin Hoque, Sukhen Das

    A biocompatible poly(vinylidene) difluoride (PVDF) based film has been prepared by in situ precipitation of calcium phosphate precursors. Such films were surface absorbed with two essential oils namely eucalyptus and tea tree oil. Physico-chemical characterization of the composite film revealed excellent stability of the film with 10% loading of oils in the PVDF matrix. XRD, FTIR and FESEM measurements confirmed the presence of hydroxyapatite and octacalcium phosphate in the PVDF matrix which showed predominantly β phase. Strong bactericidal activity was observed with very low minimum bactericidal concentration (MBC) values on both E. coli and S. aureus. The composite films also resisted biofilm formation as observed by FESEM. The release of essential oils from the film showed an initial burst followed by a very slow release over a period of 24 hours. Antibacterial action of the film was found to be primarily due to the action of essential oils which resulted in leakage of vital fluids from the microorganisms. Both necrotic and apoptotic morphologies were observed in bacterial cells. Biocompatibility studies with the composite films showed negligible cytotoxicity to mouse mesenchymal and myoblast cells at MBC concentration.


  • Open Access

    Formulation of nanotized curcumin and demonstration of its antimalarial efficacy

    by Aparajita Ghosh, Tanushree Banerjee, Avadhesha Surolia, Suman Bhandary

    Aim: The present study was conducted to overcome the disadvantages associated with the poor water solubility and low bioavailability of curcumin by synthesizing nanotized curcumin and demonstrating its efficacy in treating malaria. Materials and methods: Nanotized curcumin was prepared by a modified emulsion-diffusion-evaporation method and was characterized by means of transmission electron microscopy, atomic force microscopy, dynamic light scattering, Zetasizer, Fourier transform infrared spectroscopy, and differential thermal analysis. The novelty of the prepared nanoformulation lies in the fact that it was devoid of any polymeric matrices used in conventional carriers. The antimalarial efficacy of the prepared nanotized curcumin was then checked both in vitro and in vivo. Results: The nanopreparation was found to be non-toxic and had a particle size distribution of 20–50 nm along with improved aqueous dispersibility and an entrapment efficiency of 45%. Nanotized curcumin (half maximal inhibitory concentration [IC50]: 0.5 µM) was also found to be ten-fold more effective for growth inhibition of Plasmodium falciparum in vitro as compared to its native counterpart (IC50: 5 µM). Oral bioavailability of nanotized curcumin was found to be superior to that of its native counterpart. Moreover, when Plasmodium berghei-infected mice were orally treated with nanotized curcumin, it prolonged their survival by more than 2 months with complete clearance of parasites in comparison to the untreated animals, which survived for 8 days only. Conclusion: Nanotized curcumin holds a considerable promise in therapeutics as demonstrated here for treating malaria as a test system.